AMLX - Amylyx Pharmaceuticals, Inc.
IEX Last Trade
4.01
-0.060 -1.496%
Share volume: 14,193
Last Updated: Thu 26 Dec 2024 08:30:32 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$4.07
-0.06
-1.47%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-13 | 2023-05-11 | 2023-08-10 | 2023-11-09 | 2024-02-22 | 2024-05-09 | |
| Total revenue | 0.000 | 345.000 K | 21.885 M | 71.428 M | 98.216 M | 102.693 M | 108.449 M | 88.643 M | |
| Cost of revenue | 0.000 | 172.000 K | 2.821 M | 5.283 M | 5.580 M | 5.218 M | 9.360 M | 5.945 M | |
| Gross profit | 0.000 | 173.000 K | 19.064 M | 66.145 M | 92.636 M | 97.475 M | 99.089 M | 82.698 M | |
| inf% | 10,919.65% | 246.96% | 40.05% | 5.22% | 1.66% | -16.54% | |||
| Operating expenses | 54.253 M | 54.854 M | 63.657 M | 68.198 M | 72.435 M | 78.755 M | 97.155 M | 94.367 M | |
| Selling general and admin | 29.994 M | 29.940 M | 40.844 M | 44.006 M | 43.391 M | 48.718 M | 52.241 M | 57.759 M | |
| Research and development | 24.259 M | 24.914 M | 22.813 M | 24.192 M | 29.044 M | 30.037 M | 44.914 M | 36.608 M | |
| Total expenses | 54.253 M | 55.026 M | 66.478 M | 73.481 M | 78.015 M | 83.973 M | 106.515 M | 100.312 M | |
| 1.42% | 20.81% | 10.53% | 6.17% | 7.64% | 26.84% | -5.82% | |||
| Operating income | -54.253 M | -54.681 M | -44.593 M | -2.053 M | 20.201 M | 18.720 M | 1.934 M | -11.669 M | |
| Ebit | -54.253 M | -54.681 M | -44.593 M | -2.053 M | 20.201 M | 18.720 M | 1.934 M | -11.669 M | |
| Pretax income | -53.893 M | -53.881 M | -42.125 M | 1.403 M | 24.007 M | 22.411 M | 6.476 M | -118.551 M | |
| -0.02% | -21.82% | -103.33% | 1,611.12% | -6.65% | -71.10% | -1,930.62% | |||
| Income tax | 174.000 K | -125.000 K | 579.000 K | -170.000 K | 1.933 M | 1.518 M | 1.745 M | 242.000 K | |
| Net income basic | -54.067 M | -53.756 M | -42.704 M | 1.573 M | 22.074 M | 20.893 M | 4.731 M | -118.793 M | |
| 0.58% | 20.56% | 103.68% | 1,303.31% | -5.35% | -77.36% | -2,610.95% | |||
| Net income | -54.067 M | -53.756 M | -42.704 M | 1.573 M | 22.074 M | 20.893 M | 4.731 M | -118.793 M | |
| 0.58% | 20.56% | 103.68% | 1,303.31% | -5.35% | -77.36% | -2,610.95% |